SETTLEMENT AGREEMENT
Exhibit 10.2
This Settlement Agreement (“Agreement”) is effective as of the latest date set out on the signature page hereof (the “Effective Date”), among Xxxxxx Electronics Corporation, a New York corporation having a place of business at 000 Xxxxxxx Xxx., Xxxxx 0X, Xxxxxxx, Xxx Xxxx 00000 (“Xxxxxx”); and Conexant Systems, Inc., a Delaware corporation having a place of business at 0000 Xxxx Xxxxxx, Xxxxx 000, Xxxxxx, XX 00000 (“Conexant”) (Xxxxxx and Conexant may each be referred to as a “Party” or collectively be referred to as the “Parties”).
RECITALS
WHEREAS, the Parties wish to resolve the litigation pending in the International Trade Commission Investigation No. 337-TA-949 titled Certain Audio Processing Hardware and Software and Products Containing the Same (the “ITC Investigation”) in which Conexant intervened;
WHEREAS, Xxxxxx has granted Conexant and its Subsidiaries a license to the Asserted Patents, the License Agreement being attached hereto as Confidential Exhibit A.
In consideration of the mutual promises and covenants herein contained, Xxxxxx and Conexant agree as follows:
AGREEMENT
SECTION 1: DEFINITIONS
As used in this Agreement, the following terms shall have the following meanings which shall include both singular and plural forms in context. Additional terms may be defined elsewhere in this Agreement.
1.1. “Asserted Patents” means all patents asserted by Xxxxxx in the ITC Investigation, namely, the following U.S. Patents: 5,825,898; 6,049,607; 6,363,345; 6,483,923; and 6,377,637.
1.2. “Control” (including its correlative meanings, “Controlled” and “Controlling”) means the power to direct or cause the direction of the management and policies of an Entity whether through ownership of voting securities, by contract or otherwise; it being understood and agreed that with respect to a corporation, limited liability company, partnership, and similar structures, “Control” shall also require (a) ownership of more than fifty percent (50%) of the voting stock, limited liability interest, partnership interest, or other voting interest (or equivalent interest), in any such corporation, limited liability company, or partnership, or (b) in any country where it is not permitted by law to own more than fifty percent (50%) of the voting stock, limited liability interest, partnership interest, or other voting interest (or equivalent interest) in a local corporation, limited liability company, or partnership, ownership of the maximum legally allowed ownership interest of the voting stock, limited liability interest, partnership interest, or other voting interest (or equivalent interest) of the local corporation, limited liability company, or partnership.
Page 1 of 6
1.3. “Entity” means a natural person, corporation, association, joint venture, partnership, company, limited liability company or other legal entity recognized in any jurisdiction in the world.
1.4. “License Agreement” shall mean the License Agreement between Xxxxxx and Conexant, attached as Confidential Exhibit A.
1.5. “Subsidiary” shall mean any Entity directly or indirectly Controlled by a Party, as of the Effective Date.
SECTION 2: DISMISSALS
2.1. Dismissals. Subject to the terms and conditions herein the Parties shall file the following:
| a. | Xxxxxx and Conexant shall jointly file a motion to terminate the ITC Investigation substantially in the form set forth in Exhibit B within five (5) days of the Effective Date. |
2.2. Releases. Upon receipt of payment by Xxxxxx as set forth in Section 3.1 of the License Agreement, Xxxxxx and its Subsidiaries and Conexant, its parent and Conexant’s Subsidiaries shall release all claims, counterclaims and/or defenses against each other relating to the Asserted Patents that were brought or could have been brought of any kind and nature whatsoever, including but not limited to any claims in the ITC Investigation, as of the Effective Date.
| a. | With respect to any and all claims released herein, each Party stipulates and agrees that they shall be deemed to have expressly waived any and all provisions, rights and benefits conferred by any law of any country, state or territory, or principle of common law, which is similar, comparable, or equivalent to Cal. Civ. Code § 1542, which provides: | ||
| A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR. | |||
| Each Party acknowledges that the inclusion of such unknown claims in the releases above was separately bargained for and was a key element of this Agreement. Each Party acknowledges that they may hereafter discover facts which are different from or in addition to those that they may now know or believe to be true with respect to any and all claims herein released and agree that all such unknown claims are nonetheless released and that the releases above shall be and remain effective in all respects even if such different or additional facts are subsequently discovered. | |||
Page 2 of 6
2.3. No Costs. The Parties agree that this Agreement is intended solely as a compromise between the Parties and without any acknowledgment of liability, fault, or damages. The Parties acknowledge and agree that each Party shall bear its own attorneys’ fees, court costs, expenses, and any other related costs and expenses that they have incurred in connection with any and all claims previously filed against each other. The Parties also agree that they shall bear their own costs and attorneys’ fees relating to or arising from the negotiation and performance of this Agreement.
SECTION
3
MISCELLANEOUS
3.1. Term. The rights granted under this Agreement, if any, shall commence upon the Effective Date.
3.2. No Other Obligations. Neither Party shall have any other responsibilities or obligations in connection with actions to enforce or defend the Asserted Patents.
3.3. Binding on Successors. This Agreement shall be binding upon and inure to the benefit of the Parties, successors and assignees. Notwithstanding the preceding, it is understood that no assignment will release either Party or their Subsidiaries from any of their obligations hereunder.
SECTION 4
NOTICE
4.1. Written Notices. Any notices under this Agreement shall be in writing and shall be delivered by facsimile transmission, electronic mail, overnight express mail or express courier service to such Party at the address given below, or such other address as provided by a Party by written notice in accordance with this Section, and shall be effective on receipt. Notwithstanding the foregoing, notices and other communications sent by facsimile transmission or electronic mail shall be effective upon the sender’s receipt of an acknowledgement from the intended recipient. This paragraph in no way constitutes waiver of service of process in any litigation between the parties.
| For Xxxxxx: | Xxxxxx Electronics Corporation | ||
| 000 Xxxxxxx Xxx., Xxxxx 0X | |||
| Xxxxxxx, Xxx Xxxx 00000 | |||
| For Conexant: | Conexant Systems, Inc. | ||
| 0000 Xxxx Xxxxxx, Xxxxx 000 | |||
| Xxxxxx, XX 00000 | |||
| Attn: General Counsel |
Page 3 of 6
SECTION 5
GOVERNING LAW AND
JURISDICTION
5.1. Governing Law. The Parties agree that this Agreement shall be considered to have been made in, and construed and interpreted in accordance with the substantive laws of the State of California, without regard to its conflict of laws principles.
5.2. Jurisdiction. The Parties hereby submit to, and waive any venue objections against, the sole and exclusive jurisdiction of the state and federal courts located in Orange County in the State of California.
SECTION 6
WARRANTIES; COVENANTS;
LIMITATION OF LIABILITY
6.1. Limited Warranty. Each Party represents and warrants that it has the full authority to enter into and fully perform this Agreement; and that this Agreement is valid and binding and enforceable in accordance with its terms.
SECTION
7
CONFIDENTIALITY
7.1. Duty to Maintain Confidentiality. Either Party may publicly disclose this Agreement, except that the License Agreement, Confidential Exhibit A, may only be disclosed in accordance with the Confidentiality obligations contained therein.
SECTION
8
MISCELLANEOUS
8.1. Counterparts. This Agreement may be executed in counterparts in the English language and each executed document shall be deemed an original thereof.
8.2. Entire Agreement; Construction. This Agreement constitutes the entire agreement between the Parties concerning the subject matter hereof and supersedes all written and oral prior agreements and understandings with respect thereto.
8.3. Modification. No variation or modification of the terms of this Agreement or any waiver of any of the terms or provisions hereof shall be valid unless in writing and signed by an authorized representative of each of the Parties.
8.4. Severability; Interpretation. This Agreement is subject to the restrictions, limitations, terms and conditions of all applicable governmental regulations, approvals and clearances. If any term or provision of this Agreement is held invalid, illegal or unenforceable in any respect for any reason, that invalidity, illegality or unenforceability shall not affect any other term or provision hereof, and this Agreement shall be interpreted and construed as if such term or provision, to the extent the same shall have been held to be invalid, illegal or unenforceable, had never been contained herein, and instead had been included in such manner as to lawfully effectuate the intent of such term or provision. The Parties acknowledge that each Party was represented by legal counsel in connection with this Agreement and that each of them and its counsel have reviewed this Agreement, and that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement or any applicable amendments or any exhibits.
Page 4 of 6
8.5. Waiver. Failure by either Party to enforce any rights under this Agreement for any length of time shall not be construed as a waiver of such rights nor shall a waiver by either Party in one or more instances be construed as constituting a continuing waiver or as a waiver in other instances.
8.6. Remedies. In the event of a breach of this Agreement, in addition to the right to enforce its rights under this Agreement, each Party shall retain any and all rights and/or remedies, at law or in equity.
8.7. No Admission. The Parties agree that this Agreement or anything contained herein shall not constitute an admission by Conexant of infringement, validity or enforceability of any of the Asserted Patents.
*******************************
Page 5 of 6
IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by duly authorized officers effective on the Effective Date.
Xxxxxx Electronics Corporation
| By: | /s/ Xxxxxxx Xxxxxx |
| Name: | Xxxxxxx Xxxxxx |
| Title: | CEO |
| Date: | 2/16/2016 |
| Conexant Systems, Inc. | |
| By: | /s/ Xxxxx Xxxxxxxx |
| Name: | Xxxxx Xxxxxxxx |
| Title: | President and CEO |
| Date: | 2/16/2016 |
Page 6 of 6
